Log in

NASDAQ:CRVSCorvus Pharmaceuticals Earnings Date, Estimates & History

-0.15 (-4.35 %)
(As of 06/1/2020 04:00 PM ET)
Today's Range
Now: $3.30
50-Day Range
MA: $3.03
52-Week Range
Now: $3.30
Volume176,636 shs
Average Volume162,148 shs
Market Capitalization$92.24 million
P/E RatioN/A
Dividend YieldN/A


Corvus Pharmaceuticals (NASDAQ:CRVS) Earnings Information

Corvus Pharmaceuticals last issued its earnings data on April 30th, 2020. The reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by $0.04. Corvus Pharmaceuticals has generated ($1.59) earnings per share over the last year. Corvus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 6th, 2020 based off prior year's report dates.

Corvus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Corvus Pharmaceuticals (NASDAQ:CRVS) Earnings Estimates

2020 EPS Consensus Estimate: ($1.39)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.33)($0.33)($0.33)
Q2 20201($0.33)($0.33)($0.33)
Q3 20201($0.33)($0.33)($0.33)
Q4 20201($0.40)($0.40)($0.40)

Corvus Pharmaceuticals (NASDAQ CRVS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/29/2019Q3 2019($0.42)($0.37)($0.37)Transcript
8/1/2019Q2 2019($0.42)($0.44)($0.44)Transcript
8/2/2018Q2 2018($0.6450)($0.40)($0.40)N/A
5/3/2018Q1 2018($0.7360)($0.63)($0.63)N/A
3/1/2018Q4 2017($0.7650)($0.58)($0.58)N/A
11/2/2017Q3 2017($0.8140)($0.62)($0.62)N/A
8/3/2017Q2 2017($0.76)($0.73)($0.73)N/A
5/4/2017Q1 2017($0.79)($0.79)N/A
11/3/2016Q3 2016($0.45)($0.51)($0.51)N/A
8/4/2016Q2 2016($0.36)($0.43)($0.43)N/A
5/5/2016Q1 2016($5.39)($5.39)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.